Cami S. Sima
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Thyroid Cancer Diagnosis and Treatment, Hemophilia Treatment and Research
Most-Cited Works
- → Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases(2011)990 cited
- → Variation of Breast Cancer Risk Among BRCA1/2 Carriers(2008)281 cited
- → Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers(2016)118 cited
- → A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma(2016)117 cited
- → Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer(2017)70 cited
- → A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer(2016)62 cited
- → Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers(2016)57 cited
- → Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer(2019)6 cited
- → Estimating the Risk of Myocardial Infarction in Persons with Hemophilia A Using a Machine-Learning Approach with US Claims Data(2019)5 cited
- → Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data(2010)5 cited